- Home
- PRLD vs CULP Comparison
PRLD vs CULP Comparison
Compare PRLD & CULP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PRLD
- CULP
- Stock Information
- Founded
- PRLD 2016
- CULP 1972
- Country
- PRLD United States
- CULP United States
- Employees
- PRLD N/A
- CULP N/A
- Industry
- PRLD Medicinal Chemicals and Botanical Products
- CULP Textiles
- Sector
- PRLD Health Care
- CULP Consumer Discretionary
- Exchange
- PRLD Nasdaq
- CULP Nasdaq
- Market Cap
- PRLD 73.7M
- CULP 62.9M
- IPO Year
- PRLD 2020
- CULP N/A
- Fundamental
- Price
- PRLD $1.39
- CULP $5.68
- Analyst Decision
- PRLD Strong Buy
- CULP
- Analyst Count
- PRLD 2
- CULP 0
- Target Price
- PRLD $4.50
- CULP N/A
- AVG Volume (30 Days)
- PRLD 783.6K
- CULP 28.1K
- Earning Date
- PRLD 02-13-2025
- CULP 12-04-2024
- Dividend Yield
- PRLD N/A
- CULP N/A
- EPS Growth
- PRLD N/A
- CULP N/A
- EPS
- PRLD N/A
- CULP N/A
- Revenue
- PRLD $3,000,000.00
- CULP $222,157,000.00
- Revenue This Year
- PRLD N/A
- CULP $1.94
- Revenue Next Year
- PRLD N/A
- CULP $10.13
- P/E Ratio
- PRLD N/A
- CULP N/A
- Revenue Growth
- PRLD N/A
- CULP N/A
- 52 Week Low
- PRLD $0.80
- CULP $4.25
- 52 Week High
- PRLD $6.80
- CULP $6.85
- Technical
- Relative Strength Index (RSI)
- PRLD 60.84
- CULP 55.47
- Support Level
- PRLD $1.12
- CULP $5.29
- Resistance Level
- PRLD $1.48
- CULP $5.86
- Average True Range (ATR)
- PRLD 0.18
- CULP 0.23
- MACD
- PRLD 0.05
- CULP 0.03
- Stochastic Oscillator
- PRLD 74.78
- CULP 64.38
About PRLD Prelude Therapeutics Incorporated
Prelude Therapeutics Incorp is a clinical-stage precision oncology company focused on discovering and developing small molecule therapies optimized to target the key driver mechanisms in cancers with high unmet needs. The company's pipeline includes four candidates currently in clinical development: PRT1419, a potent, selective inhibitor of MCL1; PRT2527, a potent and selective CDK9 inhibitor, PRT3645, a next-generation CDK4/6 inhibitor, and PRT3789 a first-in-class SMARCA2/BRM protein degrader.
About CULP Culp Inc.
Culp Inc manufactures, sources, and markets mattress fabrics and sewn covers used for covering mattresses and box springs and upholstery fabrics including cut and sewn kits used in the production of upholstered furniture. The company has two operating segments Mattress fabrics which generates maximum revenue, and Upholstery fabrics. The mattress fabrics segment, also known as Culp Home Fashions, manufactures and markets mattress fabrics and mattress covers to bedding manufacturers. The upholstery fabrics segment markets fabrics for residential, commercial, and hospitality furniture and also provides window treatment products and installation services for its customers in the hospitality and commercial industries. Geographically, it derives key revenue from the United States of America.